Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain

NCT00090181 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00090181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00090181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2004
Completion date
March 31, 2005
Enrollment
401 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low back pain